NCT07135713 is a clinical trial in ECG Changes, sponsored by Assiut University.

Who is sponsoring NCT07135713?

NCT07135713 is sponsored by Assiut University.

What condition does NCT07135713 study?

NCT07135713 studies ECG Changes.

Is NCT07135713 still recruiting?

NCT07135713 is currently not yet recruiting. Last updated 22 August 2025.

Last reviewed 2025-08-22 · How we verify

NCT07135713

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Electrocardiographic Changes Associated With Epilepsy

Not yet recruiting Last updated 22 August 2025

What this trial tests

trial in ECG Changes in 80 participants. Not yet recruiting.

Timeline

1 October 2025

Primary endpoint
1 September 2026

1 October 2026

Quick facts

Lead sponsor	Assiut University
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	80
Start date	1 October 2025
Primary completion	1 September 2026
Estimated completion	1 October 2026

Conditions studied

ECG Changes — all drugs for ECG Changes →

Sponsor

Assiut University

Who can join

Adults 1 to 18, any sex, with ECG Changes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Identify and characterize electrocardiographic (ECG) changes occurring during the post-ictal phase of epileptic seizures. Evaluate the duration and severity of post-ictal ECG abnormalities. Assess the correlation between ECG changes and seizure type, duration, and severity. Explore the association of ECG changes with patient demographics

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07135713 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 22 August 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07135713.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing